]>
IRCT20251024067738N1 IRCT 2025-11-04 Ahvaz University of Medical Sciences Ù‹Radiofrequency ablation in thyroid nodules Effectiveness of radiofrequency ablation therapy with ultrasound guidance in thyroid nodules 2025-11-03 anticipated 48 Complete https://irct.ir/trial/87263 interventional Randomization: N/A, Blinding: Not blinded, Placebo: Not used, Assignment: Other, Purpose: Treatment. 2-3 Benign thyroid nodules - Autonomous thyroid nodule - Residual thyroid after thyroid cancer surgery - Residual metastatic lymph nodes after lymph node dissection for thyroid cancer.. Intervention group: Patients with benign nodules, autonomous thyroid nodules, thyroid remnants remaining after thyroid cancer surgery, and metastatic lymph nodes remaining after thyroid cancer lymph node dissection surgery. No - There is not a plan to make this available Justification or reason for not sharing IPD is Due to the human nature of the current study and information about the demographics, course of treatment, and clinical findings of the patients participating in this study, based on the principles of medical confidentiality and the principles of ethics in research, there is no desire to publish the data file after the end of the clinical trial.
public Abdulhasan Talaeizadeh
Ahvaz, Shahid Azadegan Street, Imam Khomeini Hospital, General Surgery Department
Ahvaz Iran (Islamic Republic of) 6193673166 +98 61 9101 0801 Ahtalaiezadeh@yahoo.com Ahvaz University of Medical Sciences scientific Abdulhasan Talaeizadeh
Ahvaz, Azadegan Street, Imam Khomeini Educational-Therapeutic Center - Surgery Department
Ahvaz Iran (Islamic Republic of) 6193673166 +98 61 3222 2818 Ahtalaiezadeh@yahoo.com Ahvaz University of Medical Sciences Iran (Islamic Republic of) Patients with a definitive and documented diagnosis of autonomous nodule or benign thyroid nodule. Patients must be over 18 years of age. Patients with residual thyroid after thyroid cancer surgery. Patients with metastatic lymph nodes after lymph node dissection surgery for thyroid cancer. Patients with benign thyroid nodules less than 20 mm without clinical symptoms. Patients with a benign thyroid nodule greater than 20 mm with clinical symptoms. Patients with autonomous thyroid nodules less than 20 ml. 18 years no limit Both Patients who do not consent to participate in the research. Patients with known cases of dementia or psychiatric cognitive disorders. Patients under 18 years of age. Patients in whom the diagnosis of autonomous nodule or benign thyroid nodule is not definitive and documented. Patients with autonomous nodules with a volume greater than 20 ml. E04.1 Nontoxic single thyroid nodule Treatment - Other Intervention group: Patients with benign nodules, autonomous thyroid nodules, thyroid remnants remaining after thyroid cancer surgery, and metastatic lymph nodes remaining after thyroid cancer lymph node dissection surgery Thyroid nodule volume reduction rate: It is created by dividing the difference between the pre- and post-thyroid nodule volume by the pre-thyroid nodule volume multiplied by 100. Timepoint: The volume of the thyroid nodule or lymph node is examined first and 3 and 6 months after the procedure. Method of measurement: The size of the thyroid nodule or lymph node is determined by ultrasonography of the thyroid or neck. Minor and major complications resulting from ultrasound-guided radio frequency ablation procedure. Timepoint: Beginning of study, 3 and 6 months after the procedure. Method of measurement: History, physical examination, thyroid and neck ultrasound, and thyroid function test. Ahvaz University of Medical Sciences Approved 2025-10-22 Research Ethics commitee, Ahvaz Jundishapur University of Medical Sciences Ahvaz, Golestan Boulevard, Ahvaz Jundishapur University of Medical Sciences, secretary for Research, Research Ethics commitee Ahvaz Khouzestan Iran (Islamic Republic of)